Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Change in Inventory: 2023-2025

Historic Change in Inventory for Tarsus Pharmaceuticals (TARS) over the last 2 years, with Sep 2025 value amounting to -$37,000.

  • Tarsus Pharmaceuticals' Change in Inventory fell 105.67% to -$37,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $988,000, marking a year-over-year decrease of 81.58%. This contributed to the annual value of $2.0 million for FY2024, which is 34.15% down from last year.
  • According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' Change in Inventory is -$37,000, which was down 103.17% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Tarsus Pharmaceuticals' Change in Inventory ranged from a high of $3.1 million in Q4 2023 and a low of -$227,000 during Q4 2024.
  • In the last 3 years, Tarsus Pharmaceuticals' Change in Inventory had a median value of $652,000 in 2024 and averaged $707,556.
  • Within the past 5 years, the most significant YoY rise in Tarsus Pharmaceuticals' Change in Inventory was 4,246.67% (2024), while the steepest drop was 107.34% (2024).
  • Tarsus Pharmaceuticals' Change in Inventory (Quarterly) stood at $3.1 million in 2023, then slumped by 107.34% to -$227,000 in 2024, then crashed by 105.67% to -$37,000 in 2025.
  • Its Change in Inventory stands at -$37,000 for Q3 2025, versus $1.2 million for Q2 2025 and $84,000 for Q1 2025.